Volitionrx (VNRX) Total Non-Current Liabilities (2011 - 2025)
Volitionrx (VNRX) reported Total Non-Current Liabilities of $31.0 million for Q3 2025, up 514.48% on a YoY basis from $5.0 million in Q3 2024, and down 4.87% quarter-over-quarter from $32.6 million in Q2 2025.
Volitionrx (VNRX) Total Non-Current Liabilities (2011 - 2025) Analysis & Trends
Volitionrx has reported Total Non-Current Liabilities for 15 years, with the latest figure at $31.0 million in Q3 2025.
- For the quarter ending Q3 2025, Total Non-Current Liabilities rose 514.48% year-over-year to $31.0 million; the trailing twelve-month figure through Sep 2025 stood at $31.0 million (up 514.48% YoY), and the FY2024 full-year result was $27.7 million, up 474.36% from the prior year.
- Total Non-Current Liabilities for Q3 2025 stood at $31.0 million, down from $32.6 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $32.6 million in Q2 2025, with the low at -$31.4 million in Q1 2021.
- Historically, Total Non-Current Liabilities has averaged $12.9 million across 5 years, with a median of $9.5 million in 2021.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities sank 524.88% — and 2025, when it surged 552.55%.
- Volitionrx's Total Non-Current Liabilities stood at $9.5 million in 2021, then sank by 57.58% to $4.0 million in 2022, then rose by 19.57% to $4.8 million in 2023, then soared by 474.36% to $27.7 million in 2024, then increased by 11.76% to $31.0 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $31.0 million (Q3 2025), $32.6 million (Q2 2025), and $29.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Volitionrx | 53.00 Mn | 50.54 Mn | -1.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 30.98 Mn |
| Jun 30, 2025 | 32.56 Mn |
| Mar 31, 2025 | 29.27 Mn |
| Dec 31, 2024 | 27.72 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 4.99 Mn |
| Mar 31, 2024 | 4.56 Mn |
| Dec 31, 2023 | 4.83 Mn |
| Sep 30, 2023 | 3.24 Mn |
| Jun 30, 2023 | 22.02 Mn |
| Mar 31, 2023 | 20.60 Mn |
| Dec 31, 2022 | 4.04 Mn |
| Sep 30, 2022 | 20.11 Mn |
| Jun 30, 2022 | 20.06 Mn |
| Mar 31, 2022 | 20.63 Mn |
| Dec 31, 2021 | 9.52 Mn |
| Sep 30, 2021 | 8.56 Mn |
| Jun 30, 2021 | 8.34 Mn |
| Mar 31, 2021 | -31.41 Mn |
| Dec 31, 2020 | 9.60 Mn |